2026³â 07¿ù 04ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

HOLLYWOOD, FLA. -- The Additive Manufacturer Green Trade Association (AMGTA) today announced that EOS has elevated its longstanding participation in t

AI-enhanced intellectual property search solution simplifies complex research and expands curated content access.
´º½ºÀÏÀÚ: 2026-02-23

COLUMBUS, OHIO -- CAS, a division of the American Chemical Society specializing in scientific knowledge management, announced complete functionality for CAS IP Finder™, powered by STN™. CAS STNext® customers can now access the full intellectual property search solution across all search methods, expanded content collections, and advanced analysis tools.

Patent volume continues to grow, and scientific disciplines are increasingly interconnected, making intellectual property research more complex and increasing the risk of missed prior art. Organizations traditionally chose between empowering specialized searchers with comprehensive tools or providing limited capabilities to broader teams. CAS IP Finder eliminates that compromise by providing flexible access points that connect users of all experience levels to curated content and precise search tools.

“As scientific and patent data grow in complexity, organizations need IP search solutions that enable access across entire teams,” said Manuel Guzman, President, CAS. “CAS IP Finder enables broader participation in IP research while maintaining the depth and accuracy that complex patent work demands, supporting faster, evidence-based decisions.”

Easier access to comprehensive databases without sacrificing precision

CAS IP Finder maintains access to more than 100 scientific, patent, and non-patent literature databases that have been the foundation of STN for decades. Now, users can search this wealth of data without command-line knowledge while preserving the precision IP professionals require. New capabilities include:

· An intuitive query builder enabling high-quality searches without traditional learning curves.
· Proprietary AI-enhanced exploratory search that analyzes text using machine learning and natural language processing.
· Expanded life sciences content embedded specifically to help IP professionals find critical information in complex datasets.
· Interactive visualization tools for exploring patterns in large datasets.
· Enhanced reporting features with customizable keyword highlighting and formatting options.

Among these capabilities, proprietary exploratory search stands out as a unique advancement in IP research, analyzing text input to identify relevant patents and non-patent documents, detecting key terms, and suggesting refinements that improve relevance without requiring specialized syntax knowledge. Patent examiners have adopted this approach because it delivers insights previously unavailable through conventional searches.

“The challenge was maintaining the precision and depth of CAS STNext while eliminating the traditional command-line barrier,” said Tim Wahlberg, Chief Product Officer, CAS. “Our proprietary exploratory search uses machine learning trained on the CAS Content Collection to deliver insights that patent examiners are now relying on. We have made complex IP research accessible without compromising accuracy.”

The solution also addresses specific needs in pharmaceutical and biotechnology research. The CAS Bioactivity file, curated by CAS scientists, provides normalized structure-activity relationships, ADME, and toxicity data structured specifically to support patent research workflows. This targeted approach helps researchers pinpoint critical information that would be difficult to locate through conventional methods, reducing risk in drug discovery and development.



 Àüü´º½º¸ñ·ÏÀ¸·Î

SLB OneSubsea and Subsea7 Sign Collaboration Agreement with PETRONAS Suriname
Blue Cloud Ventures Announces Final Close of Blue Cloud Ventures V
NetApp and Cisco Collaboration Strengthens Defense-in-Depth for Enterprise Cyber Resilience
AAHI¡¯s SLA-SE Adjuvant Drives Lilly¡¯s Curevo Shingles Vaccine Acquisition
comforte Launches TAMUNIO Assure to Modernize HPE Nonstop Cryptography for the Post-Quantum Era
Semiconductor Market Surpasses $300bn Quarterly Revenue in 1Q26
SES Launches Multi-Orbit Satellite Connectivity on Mexico¡¯s Viva

 

Biocytogen Unveils AI-Powered RenSuper Platform and First Fully Automa...
Kwon Oh-tae from Donghae Aqua Unveils VINE7, a Seven-Day Vinegar Ferme...
RevBits, Stony Brook Ethos Lab Partner to Advance Cybersecurity Educat...
Silicon Motion Achieves ISO 26262 Certification for Automotive Applica...
Poland¡¯s Poznan University of Technology Unveils IQM Quantum Computer...
ASC26 Student Supercomputer Challenge Concluded
2026 Esri User Conference to Focus on Creating a More Intelligent Worl...

 


°øÁö»çÇ×
¹Ìµð¾î¿Í M• Mediaour ØÚ体ä² ØÚô÷ä² ¿¥¿À MO ØÚä²
¾Ë¸®¾Ë A⋮⋮⋮ Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
À£ÇÁ·Ò W⋮⋮⋮ Welfrom 卫ÜØ êÛÝ£
¹ÙÀÌ¿ÀÀÌ´Ï B⋮ BIOINI ù±药研 ¹ÙÀÌ¿ÀÀÌ´Ï·¦ BIOINILAB ...
º£³×ÀÍ ¡Õ Beneik 宝Ò¬ìÌ, À̺ñÁî eBizh æ¶币òª EZ æ¶òª
¿¡³ÊÀÌÀ¯ ¡Õ¡Õ EnerEU 额Òö äþÒö
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ºÁö'
¾Ë¸®À¯ºñ ^v Alliuv ä¹备 AV ä¹êó备, ¾Ë¶ã =^= Althle ä¹÷åìÌ
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º ¡ÕC À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¾ËÇÁ·Ò ^ Alfrom ä¹尔ÜØ ä¹ì³ÜØ, ¿ÃÇÁ·Ò A⋮⋮ Allfrom &...

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..